Virbac broadens its bovine respiratory disease vaccine portfolio
Virbac is expanding its BOVIGEN Platinum vaccine line with BOVIGEN Platinum Synvera, an eight-way vaccine developed for...
FDA introduces a risk-based approach to residue analytical methods
The US Food and Drug Administration’s Center for Veterinary Medicine (CVM) has launched a voluntary pilot...
Pomerantz Opens Neogen Investor Investigation Following FDA Warning Over Contaminated Veterinary Product
UNITED STATES — 28 October 2026: Pomerantz LLP has launched an investigation into...
The global veterinary injectables market is projected to expand from US$25.6 billion in 2026 to US$46.5 billion by 2033, representing a reported compound annual...
Executive perspective: Pet Food is Becoming more than a Food Category
The global pet food industry is approaching a strategic inflection point. Its next phase...
Integrated antibody R&D targets a key bottleneck in veterinary biologics
27 October 2026 — Animal Health Biotechnology: Creative Biolabs is highlighting an integrated research and...
UNITED STATES — 26 October 2026: Companion-animal biotechnology company VETARYS has announced a research collaboration with Antigenesis Biologics to develop an investigational combination immunotherapy...
Eko Vet+ | CANINEBEAT AI combines digital auscultation and artificial intelligence to help veterinarians identify heart murmurs associated with structural heart disease and facilitate...
Redwood City-based Familiar Therapeutics has launched with US$5 million in seed funding to develop veterinary medicines from drug programmes originating in human pharmaceutical research....
WELLINGTON, New Zealand — AgriZeroNZ, the joint public-private entity driving New Zealand’s agricultural emissions-reduction pipeline, has secured an additional NZ$117 million (approx. US$65.7 million)...
